Skip to content

Post-operative Cesarean Trial of Pain Control

Double Blind Randomized Trial of Post-operative Cesarean Continuous Infusion of Bupivacaine Versus Placebo for Local Incisional Pain Control

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05131178
Enrollment
100
Registered
2021-11-23
Start date
2021-11-07
Completion date
2027-05-01
Last updated
2026-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section, Post-operative Pain

Brief summary

This study plans to learn more about postoperative pain management after cesarean deliveries (C-sections). As a part of standard of care, the Children's Hospital Colorado's Colorado Fetal Care Center (CFCC) follows the standard Enhanced Recovery After Cesarean (ERAC) guidelines to manage pain following C-section delivery. In addition, the CFCC uses an FDA approved medical device called the ON-Q ® Pump, which continuously delivers local anesthetic medication to control pain in the area of your procedure. The local anesthetic used is bupivacaine, which is FDA approved for use to control local pain after C-sections. The CFCC has found a significant reduction in opioid use after adopting both of these procedures. The study aims to determine if the ERAC protocol or ON-Q ® Pump continuous infusion is responsible for lower opioid use by comparing bupivacaine (treatment) versus saline (placebo) groups.

Interventions

DEVICEON-Q Pump® with continuous infusion of bupivacaine

270 ml of 0.5 % bupivacaine. The device being used is a fixed flow pump meaning the rate of 2 mL/hour. The pump is connected to the catheter and left in place for up to 4 post-operative days or until the completion of the infusion.

DEVICEON-Q Pump® with continuous infusion of saline

270 mL of normal saline. The device being used is a fixed flow pump meaning the rate of 2 mL/hour. The pump is connected to the catheter and left in place for up to 4 post-operative days or until the completion of the infusion.

Sponsors

University of Colorado, Denver
Lead SponsorOTHER
Avanos Medical
CollaboratorOTHER
Children's Hospital Colorado
CollaboratorOTHER
Colorado Fetal Care Center
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Pregnant patients 18 years of age or older * Patients undergoing both scheduled and unscheduled cesarean deliveries at CFCC

Exclusion criteria

* Active substance abuse (ex methamphetamines) determined by patient report, toxin screen, or screening physician's determination * Current treatment for chronic pain involving opiate receptor agonism or antagonism (i.e. suboxone, methadone, naltrexone, oxycodone) * Contraindication to neuraxial anesthesia * Known allergies to common anesthetic medications * Inability to consent to study procedures * Patient receiving general anesthesia

Design outcomes

Primary

MeasureTime frameDescription
Total postoperative opioid usePost-operative day 4Total postoperative opioid use in morphine equivalents through discharge

Secondary

MeasureTime frameDescription
Patient satisfaction survey with Visual Analog Scale (VAS) Pain ScoreAt hospital discharge (about post-operative day 5)The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" (score of 0) and "worst pain" (score of 100 \[100-mm scale\]).
Antiemetic use at BaselineBaselineDaily antiemetic use by number of doses through discharge
Antiemetic use at post-operative day 1Post-operative day 1Daily antiemetic use by number of doses through discharge
Antiemetic use at post-operative day 2Post-operative day 2Daily antiemetic use by number of doses through discharge
Antiemetic use at post-operative day 3Post-operative day 3Daily antiemetic use by number of doses through discharge
Antiemetic use at post-operative day 4Post-operative day 4Daily antiemetic use by number of doses through discharge
Antiemetic use at hospital discharge (about post-operative day 5)At hospital discharge (about post-operative day 5)Daily antiemetic use by number of doses through discharge
Visual Analog Scale (VAS) Pain Score at BaselineBaselineThe visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" (score of 0) and "worst pain" (score of 100 \[100-mm scale\]).
Visual Analog Scale (VAS) Pain Score at post-operative day 1Post-operative day 1The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" (score of 0) and "worst pain" (score of 100 \[100-mm scale\]).
Visual Analog Scale (VAS) Pain Score at post-operative day 2Post-operative day 2The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" (score of 0) and "worst pain" (score of 100 \[100-mm scale\]).
Visual Analog Scale (VAS) Pain Score at post-operative day 3Post-operative day 3The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" (score of 0) and "worst pain" (score of 100 \[100-mm scale\]).
Visual Analog Scale (VAS) Pain Score at post-operative day 4Post-operative day 4The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" (score of 0) and "worst pain" (score of 100 \[100-mm scale\]).
Time to advance to regular dietUp to post-operative day 4Time to advance to regular diet through discharge
Time to first ambulationUp to post-operative day 4Time to first ambulation
Return on bowel functionUp to post-operative day 4Return on bowel function (pass gas or bowel movement)
Edinburgh Depression scale at hospital discharge (about post-operative day 5)At hospital discharge (about post-operative day 5)The 10-item Edinburgh Depression Scale (EDS) measures depressive symptoms. It includes three sub-scales: anhedonia, anxiety and depression. Possible total scores range from 0 to 30, with higher scores indicating more depressive symptoms and a worse outcome.

Countries

United States

Contacts

CONTACTClinical Research Manager
Kaylene.Ross@childrenscolorado.org720-777-7080
CONTACTDeion Pena
Deion.pena@childrenscolorado.org
PRINCIPAL_INVESTIGATORMichael Zaretsky, MD

Children's Hospital Colorado - Colorado Fetal Care Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026